The release of Oprexa | Sana Pharma
The release of Oprexa
Home » SANA Pharma News » The release of Oprexa
Friday, November 11, 2022

Sana Pharma proudly announces the release of a new medication in the Jordanian market.

Oprexa, Olanzapine, is an oral atypical antipsychotic, that is used for the treatment of schizophrenia and of acute and maintenance bipolar I disorder. Oprexa is a highly effective antipsychotic in improving negative, positive, and cognitive symptoms with low incidence of extrapyramidal symptoms (EPS) and prolactin elevation.